Blue Jet Healthcare IPO

Blue Jet Healthcare IPO Overview

Issue Size: Blue Jet Healthcare IPO is a book-built issue of Rs 840.27 crores.
Offer for Sale: The entire issue consists of an offer for sale of 2.43 crore shares.
IPO Subscription Dates: The IPO opens for subscription on October 25, 2023, and closes on October 27, 2023.
Allotment Date: The allotment for the Blue Jet Healthcare IPO is expected to be finalized on Wednesday, November 1, 2023.
Listing Date: Blue Jet Healthcare IPO will list on BSE and NSE with a tentative listing date set as Monday, November 6, 2023.
Price Band: The price band for Blue Jet Healthcare IPO is set at ₹329 to ₹346 per share.
Minimum Lot Size: The minimum lot size for an application is 43 shares.
Minimum Investment: Retail investors require a minimum investment of ₹14,878.
Minimum Lot Size for sNII: Qualified Institutional Buyers (sNII) need 14 lots (602 shares), amounting to ₹208,292.
Minimum Lot Size for bNII: Non-Institutional Buyers (bNII) must invest in 68 lots (2,924 shares), amounting to ₹1,011,704.
Lead Managers: Kotak Mahindra Capital Company Limited, ICICI Securities Limited, and J.P. Morgan India Private Limited are the book running lead managers.
Registrar: Link Intime India Private Ltd is the registrar for the issue.
Anchor Investors: Blue Jet Healthcare IPO raised Rs 252.08 crore from anchor investors, with the anchor bid date set as October 23, 2023.

Promoters: Akshay Bansarilal Arora, Shiven Akshay Arora, and Archana & Akshay Arora are the promoters of the company.

Incorporation: Incorporated in 1968, Blue Jet Healthcare is a pharmaceutical and healthcare ingredient and intermediate company.
Product Categories: The company mainly deals in three product categories: (i) contrast media intermediates, (ii) high-intensity sweeteners, and (iii) pharma intermediates and active pharmaceutical ingredients.
Global Presence: Blue Jet Healthcare is a global, science-led pharmaceutical company with capabilities in process development, production, regulatory support, and collaboration in advanced pharmaceutical intermediates and APIs.
Manufacturing Facilities: The company has three manufacturing facilities located in Shahad (Unit I), Ambernath (Unit II), and Mahad (Unit III) in Maharashtra, India, with varying annual installed capacities.
Financial Performance: Blue Jet Healthcare Limited’s revenue increased by 5.98%, and profit after tax (PAT) dropped by -11.88% between the financial year ending with March 31, 2023, and March 31, 2022.
Market Cap and P/E: Blue Jet Healthcare IPO Market Cap is Rs 6001.9 Cr, and the P/E (x) is 37.49.

Use of Proceeds: The company will not receive any proceeds from the Offer, and all the Offer Proceeds will be received by the Selling Shareholders, in proportion to the Offered Shares sold by the respective Selling Shareholders as part of the Offer.